Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-Xa levels of enoxaparin after bariatric surgery in obese adults
NL-OMON37877Active, not recruiting
- Sponsor
- Slotervaartziekenhuis
- Start
- Jul 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of enoxaparin in venous thromboembolism (VTE), sponsored by Slotervaartziekenhuis. Primary endpoints: Anti-Xa peak concentration and Correlation between anti-Xa peak concentration and body weight. Started Jul 2012; status: active, not recruiting.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NL-OMON37877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37877.